mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |